SOUTH SAN FRANCISCO, Calif. (AP) _ Cytokinetics Inc. (CYTK) on Wednesday reported a loss of $76.1 million in its third quarter.

On a per-share basis, the South San Francisco, California-based company said it had a loss of 95 cents.

The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 75 cents per share.

The biopharmaceutical company posted revenue of $5.4 million in the period, also missing Street forecasts. Four analysts surveyed by Zacks expected $5.5 million.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CYTK at https://www.zacks.com/ap/CYTK

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News